Nuevas insulinas. Actualización

@inproceedings{Ceballos2009NuevasIA,
  title={Nuevas insulinas. Actualizaci{\'o}n},
  author={Leopoldo Tapia Ceballos},
  year={2009}
}
Update on new insulins Abstract Standard human insulin preparations such as regular soluble insulin and neutral protamine Hagedorn (NPH) insulin have shortcomings in terms of their pharmacokinetic and pharmacodynamic properties that limit their clinical efficacy. In the last decade, due to advances in genetic engineering, structurally modified insulin molecules have been developed with the aim of changing their galenic properties to make regular soluble insulin faster and NPH insulin slower… CONTINUE READING

References

Publications referenced by this paper.
SHOWING 1-10 OF 72 REFERENCES

Standars or medical care in diabetes -

  • B Buckingham, B Bluck, DM Wilson
  • Diabetes Care
  • 2007